Foamix Pharmaceuticals Ltd. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fff1cc39-7977-46dd-83fe-35199065bb7f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-95.2M | 2019-01-01 – 2019-12-31 | evidence 0001178913-20-000792 |
| FY 2018 | $-74.2M | 2018-01-01 – 2018-12-31 | evidence 0001178913-19-000725 |
| FY 2017 | $-65.7M | 2017-01-01 – 2017-12-31 | evidence 0001178913-18-000707 |
| FY 2016 | $-29.3M | 2016-01-01 – 2016-12-31 | evidence 0001178913-17-000582 |
| FY 2015 | $-16.5M | 2015-01-01 – 2015-12-31 | evidence 0001178913-16-004594 |
| FY 2014 | $-11.5M | 2014-01-01 – 2014-12-31 | evidence 0001178913-15-000890 |
| FY 2013 | $-2.4M | 2013-01-01 – 2013-12-31 | evidence 0001178913-15-000890 |
| FY 2012 | $-2.2M | 2012-01-01 – 2012-12-31 | evidence 0001178913-15-000890 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Foamix Pharmaceuticals Ltd. — all facts · Revenue · Operating Income